Patents by Inventor Per Peterson

Per Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mammalian retinol-binding protein receptors
    Patent number: 5679772
    Abstract: Isolated receptors for lipocalins and retinol binding proteins are disclosed, as are nucleic acid sequences coding for these molecules, and antibodies which bind to these receptors. Various uses of these materials are described as well.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 21, 1997
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Claes Olof B.ang.vik, Ulf Eriksson, Per A. Peterson
  • DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells
    Patent number: 5573939
    Abstract: Isolated receptors for lipocalins and retinol binding proteins are disclosed, as are nucleic acid sequences coding for these molecules, and antibodies which bind to these receptors. Various uses of these materials are described as well.
    Type: Grant
    Filed: February 22, 1994
    Date of Patent: November 12, 1996
    Assignee: Ludwig Institute For Cancer Research
    Inventors: Claes O. B.ang.vik, Ulf Eriksson, Per A. Peterson
  • In vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and .beta.2-microglobulin
    Patent number: 5529921
    Abstract: The present invention relates to a rational, elegant means of producing, loading and using Class I molecules to specifically activate CD8 cells in vitro, and their therapeutic applications in the treatment of a variety of conditions, including cancer, tumors or neoplasias, as well as viral, retroviral, autoimmune, and autoimmune-type diseases. The present invention also relates to vectors, cell lines, recombinant DNA molecules encoding human .beta.2 microglobulin or Class I MHC molecules in soluble and insoluble form, and methods of producing same.
    Type: Grant
    Filed: March 10, 1994
    Date of Patent: June 25, 1996
    Assignee: Scripps Research Institute
    Inventors: Per A. Peterson, Michael Jackson, Pierre Langlade-Demoyen
  • Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
    Patent number: 5314813
    Abstract: The present invention relates to a rational, elegant means of producing, loading and using Class I molecules to specifically activate CD8 cells in vitro, and their therapeutic applications in the treatment of a variety of conditions, including cancer, tumors or neoplasias, as well as viral, retroviral, autoimmune, and autoimmune-type diseases. The present invention also relates to vectors, cell lines, recombinant DNA molecules encoding human .beta.2 microglobulin or Class I MHC molecules in soluble and insoluble form, and methods of producing same.
    Type: Grant
    Filed: February 19, 1992
    Date of Patent: May 24, 1994
    Assignee: Scripps Research Institute
    Inventors: Per A. Peterson, Michael Jackson, Pierre Langlade-Demoyen
  • Continuously refining raw fibrous material to produce mechanical refiner pulp
    Patent number: 4037792
    Abstract: Raw fibrous material is preheated in a preheater in the presence of steam under a pressure greater than atmospheric pressure and then continuously introduced into a disc refiner, without prior defibration, whereby steam is generated in said disc refiner. The generated steam is continuously conducted away from said disc refiner as subsequent fibrous material is continuously being introduced into the disc refiner in order to obtain a pressure in the disc refiner which is greater than atmospheric pressure but less than the pressure in said preheater.
    Type: Grant
    Filed: September 2, 1975
    Date of Patent: July 26, 1977
    Assignee: SCA Development Aktiebolag
    Inventor: Viking Per Peterson